James A Brannigan

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 5

Top Topics

Binding Protein

Crystal Structure

Clostridium Difficile

Top Venues

Nature chemistry

Acta crystallographica. Section F, Structural biology communications

Chemical science

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

James A Brannigan, Anthony J Wilkinson
Drug discovery in leishmaniasis using protein lipidation as a target. Biophysical reviews 13 (6) (2021)
Andrew S Bell, Zhiyong Yu, Jennie A Hutton, Megan H Wright, James A Brannigan, Daniel Paape, Shirley M Roberts, Charlotte L Sutherell, Markus Ritzefeld, Anthony J Wilkinson, Deborah F Smith, Robin J Leatherbarrow, Edward William Tate
Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes. Journal of medicinal chemistry 63 (14) (2020)
Jean L Whittingham, Shumpei Hanai, James A Brannigan, William T Ferreira, Eleanor J Dodson, Johan P Turkenburg, Jared Cartwright, Simon M Cutting, Anthony J Wilkinson
Crystal structures of the GH18 domain of the bifunctional peroxiredoxin-chitinase CotE from Clostridium difficile. Acta crystallographica. Section F, Structural biology communications 76 (Pt 6) (2020)
Aurélie Mousnier, Andrew S Bell, Dawid P Swieboda, Julia Morales-Sanfrutos, Inmaculada Pérez-Dorado, James A Brannigan, Joseph Newman, Markus Ritzefeld, Jennie A Hutton, Anabel Guedán, Amin S Asfor, Sean W Robinson, Iva Hopkins-Navratilova, Anthony J Wilkinson, Sebastian L Johnston, Robin J Leatherbarrow, Tobias J Tuthill, Roberto Solari, Edward William Tate
Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virus. Nature chemistry 10 (6) (2018)
Richard J Spears, Robin L Brabham, Darshita Budhadev, Tessa Keenan, Sophie McKenna, Julia Walton, James A Brannigan, Andrzej Marek Brzozowski, Anthony J Wilkinson, Michael J Plevin, Martin A Fascione
Site-selective C-C modification of proteins at neutral pH using organocatalyst-mediated cross aldol ligations. Chemical science 9 (25) (2018)